MedTrace Logo

The Role of Aldosterone in Circulatory Disorders Within Type 2 Diabetes

NCT03017703 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 27

Last updated 2021-06-02

No results posted yet for this study

Summary

The importance of Aldosterone for endothelial function and Insulin resistance observed within patients with type 2 diabetes

Conditions

Interventions

DRUG

Eplerenone

Sponsors & Collaborators

  • University of Southern Denmark

    lead OTHER

Principal Investigators

  • Stefan P Mortensen, DMSc · University of Southern Denmark

Study Design

Allocation
NON_RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-12-01
Primary Completion
2019-10-01
Completion
2019-12-15

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03017703 on ClinicalTrials.gov